MicroRNA-31 expression in colorectal serrated pathway progression

World J Gastroenterol. 2014 Sep 14;20(34):12346-9. doi: 10.3748/wjg.v20.i34.12346.

Abstract

MicroRNAs have been increasingly recognized as useful biomarkers for colorectal cancers (CRC). We have recently observed that microRNA-31 (miR-31) expression is associated with BRAF mutation and prognosis in CRC. Moreover, high miR-31 expression is frequently detected in sessile serrated adenomas compared with hyperplastic polyps (HPs). These results suggest that miR-31 may contribute to the progression of serrated lesions. At a follow-up colonoscopy, we observed the case of a 75-year-old man with a 7-mm flat-elevated lesion in the cecum and diagnosed the lesion as an early invasive carcinoma with serrated features. Tissue specimens were obtained from the representative areas to compare the molecular alterations in the carcinoma component with those in the HP component. Higher miR-31 expression was observed in the carcinoma component (57-fold increase) and the HP component (8-fold increase) compared with the paired normal mucosa, suggesting that miR-31 may be one of the key molecules in serrated pathway progression.

Keywords: BRAF; Colorectal carcinoma; MLH1; MicroRNA-31; Microsatellite instability; Serrated pathway.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Aged
  • Biomarkers, Tumor / genetics*
  • Cecal Neoplasms / genetics*
  • Cecal Neoplasms / pathology
  • Colonoscopy
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • Humans
  • Intestinal Polyps / genetics*
  • Intestinal Polyps / pathology
  • Male
  • MicroRNAs / genetics*
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Tumor Burden

Substances

  • Biomarkers, Tumor
  • MIRN31 microRNA, human
  • MicroRNAs